Lyell Immunopharma (LYEL) Non-Current Assets (2020 - 2026)
Lyell Immunopharma's Non-Current Assets came in at $97.61 million for Q2 2026, down 5.5% from $103.24 million a year earlier but up 17.2% from the prior quarter.
Lyell Immunopharma (LYEL) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Lyell Immunopharma's Non-Current Assets was $79.11 million, down 28.9% from FY2024.
- Non-Current Assets has declined in each of the last four years, with a five-year compound annual growth rate of -22.9% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $111.27 million in FY2024 (-43.0%), $195.34 million in FY2023 (-31.8%), $286.27 million in FY2022 (-42.9%) and $501.12 million in FY2021 (+72.4%).
- The five-year range for quarterly Non-Current Assets is $79.11 million (Q4 2025) to $567.19 million (Q3 2021).
- Year-over-year, Non-Current Assets has declined for 17 consecutive quarters, with an average decline of 29.7% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in Q4 2021 (growth of 72.4%), and the weakest in Q3 2025 (a decline of 52.8%).
- Business Quant data shows LYEL's Non-Current Assets at $83.32 million (Q1 2026), $79.11 million (Q4 2025) and $79.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Lyell Immunopharma | 411.74 Mn | -470.71 Mn | - | 87.64 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 87.64 Mn |
| Jun 30, 2026 | 97.61 Mn |
| Mar 31, 2026 | 83.32 Mn |
| Dec 31, 2025 | 79.11 Mn |
| Sep 30, 2025 | 79.76 Mn |
| Jun 30, 2025 | 103.24 Mn |
| Mar 31, 2025 | 120.62 Mn |
| Dec 31, 2024 | 111.27 Mn |
| Sep 30, 2024 | 169.17 Mn |
| Jun 30, 2024 | 154.32 Mn |
| Mar 31, 2024 | 160.06 Mn |
| Dec 31, 2023 | 195.34 Mn |
| Sep 30, 2023 | 208.14 Mn |
| Jun 30, 2023 | 228.94 Mn |
| Mar 31, 2023 | 256.05 Mn |
| Dec 31, 2022 | 286.27 Mn |
| Sep 30, 2022 | 317.52 Mn |
| Jun 30, 2022 | 354.90 Mn |
| Mar 31, 2022 | 446.40 Mn |
| Dec 31, 2021 | 501.12 Mn |
Lyell Immunopharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=LYEL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();